Partillion Bioscience Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $5M

  • Investors
  • 6

Partillion Bioscience General Information

Description

Developer of the biology reagent platform designed for broadening access to advanced single-cell assays. The company's novel nano vial platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological functions such as secreted proteins, enabling biotech labs and clients to develop higher-performing therapies for cancer, autoimmune conditions, and infectious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1927 Paseo Rancho Castilla
  • Los Angeles, CA 90032
  • United States
+1 (707)
Primary Industry
Biotechnology
Corporate Office
  • 1927 Paseo Rancho Castilla
  • Los Angeles, CA 90032
  • United States
+1 (707)

Partillion Bioscience Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Partillion Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 26-Sep-2023 $5M Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Seed Round 30-Dec-2022 $4.87M $4.87M Completed Generating Revenue
1. Grant 16-Sep-2021 $1.07M Completed Generating Revenue
To view Partillion Bioscience’s complete valuation and funding history, request access »

Partillion Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-1
Seed
To view Partillion Bioscience’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Partillion Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of the biology reagent platform designed for broadening access to advanced single-cell assays. The company's n
Biotechnology
Los Angeles, CA
15 As of 2024

Ipswich, MA
 

Munich, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Partillion Bioscience Competitors (18)

One of Partillion Bioscience’s 18 competitors is New England Biolabs, a Corporation company based in Ipswich, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
New England Biolabs Corporation Ipswich, MA
Nanion Technologies Accelerator/Incubator Backed Munich, Germany
Proteros biostructures Private Equity-Backed Martinsried, Germany
Cell Signaling Technology Corporation Danvers, MA
Cellectis Formerly VC-backed Paris, France
You’re viewing 5 of 18 competitors. Get the full list »

Partillion Bioscience Patents

Partillion Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022258444-A1 Nanoscale reaction chambers and methods of using the same Pending 14-Apr-2021
CA-3215070-A1 Nanoscale reaction chambers and methods of using the same Pending 14-Apr-2021
EP-4323542-A1 Nanoscale reaction chambers and methods of using the same Pending 14-Apr-2021
EP-4323542-A4 Nanoscale reaction chambers and methods of using the same Pending 14-Apr-2021
US-12503723-B1 Nanoscale reaction chambers and methods of using the same Active 14-Apr-2021 G01N33/6854
To view Partillion Bioscience’s complete patent history, request access »

Partillion Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Partillion Bioscience Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
ND Capital Venture Capital Minority
Paladin Capital Group Venture Capital Minority
Vertical Venture Partners Venture Capital Minority
US National Science Foundation Accelerator/Incubator
General Inception Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Partillion Bioscience FAQs

  • When was Partillion Bioscience founded?

    Partillion Bioscience was founded in 2020.

  • Where is Partillion Bioscience headquartered?

    Partillion Bioscience is headquartered in Los Angeles, CA.

  • What is the size of Partillion Bioscience?

    Partillion Bioscience has 15 total employees.

  • What industry is Partillion Bioscience in?

    Partillion Bioscience’s primary industry is Biotechnology.

  • Is Partillion Bioscience a private or public company?

    Partillion Bioscience is a Private company.

  • What is Partillion Bioscience’s current revenue?

    The current revenue for Partillion Bioscience is .

  • How much funding has Partillion Bioscience raised over time?

    Partillion Bioscience has raised $9.9M.

  • Who are Partillion Bioscience’s investors?

    ND Capital, Paladin Capital Group, Vertical Venture Partners, US National Science Foundation, and General Inception are 5 of 6 investors who have invested in Partillion Bioscience.

  • Who are Partillion Bioscience’s competitors?

    New England Biolabs, Nanion Technologies, Proteros biostructures, Cell Signaling Technology, and Cellectis are some of the 18 competitors of Partillion Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process